| Authors: |
Hagen MW; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA., Setiawan NJ; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA., Dexter S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA., Woodruff KA; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA., Gaerlan FK; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA., Billings TM; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA., Orozco JJ; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Termini CM; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA.; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA. |